(MedPage Today) — An investigational mRNA-based vaccine against three strains of influenza outperformed standard flu shots among adults ages 50 and older in the Fluent randomized trial.
Reverse transcriptase-polymerase chain reaction-confirmed…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
